RA Capital Management, L.P. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-03 5:11 pm Sale |
2022-06-02 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 136,515 4.700% |
-111,277 (-44.91%) |
Filing |
| 2022-05-31 5:31 pm Sale |
2022-05-26 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 247,792 8.530% |
-74,020 (-23.00%) |
Filing |
| 2022-05-25 5:12 pm Sale |
2022-05-23 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 321,812 11.080% |
-114,773 (-26.29%) |
Filing |
| 2022-04-01 4:30 pm Sale |
2022-03-30 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 436,585 15.030% |
-1,877 (-0.43%) |
Filing |
| 2021-10-28 4:23 pm Purchase |
2009-02-28 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 438,461 16.850% |
3,477 (+0.80%) |
Filing |